- Home
- ATR vs CORT Comparison
ATR vs CORT Comparison
Compare ATR & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATR | CORT |
|---|---|---|
| Founded | 1992 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Plastic Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 7.6B |
| IPO Year | 1993 | N/A |
Fundamental Metrics
Financial Performance| Metric | ATR | CORT |
|---|---|---|
| Price | $124.63 | $78.77 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $167.50 | $139.00 |
| AVG Volume (30 Days) | ★ 787.6K | 641.7K |
| Earning Date | 10-30-2025 | 11-04-2025 |
| Dividend Yield | ★ 1.54% | N/A |
| EPS Growth | ★ 24.99 | N/A |
| EPS | ★ 6.23 | 0.87 |
| Revenue | ★ $3,662,533,000.00 | $741,172,000.00 |
| Revenue This Year | $4.30 | $28.85 |
| Revenue Next Year | $3.85 | $34.98 |
| P/E Ratio | ★ $20.02 | $90.90 |
| Revenue Growth | 2.50 | ★ 17.92 |
| 52 Week Low | $103.23 | $49.00 |
| 52 Week High | $174.10 | $117.33 |
Technical Indicators
Market Signals| Indicator | ATR | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 57.72 | 55.70 |
| Support Level | $117.37 | $73.79 |
| Resistance Level | $120.11 | $81.41 |
| Average True Range (ATR) | 2.33 | 2.85 |
| MACD | 1.25 | 0.57 |
| Stochastic Oscillator | 87.51 | 75.77 |
Price Performance
Historical ComparisonAbout ATR AptarGroup Inc.
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (49% of sales) and the United States (32%), Aptar aims to increase its presence in Asia (11%) and Latin America (8%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.